Addition Therapeutics is a biotechnology company developing all-RNA, non-viral, lipid nanoparticle (LNP)-based PRINT™ (Precise RNA-Mediated Insertion of Transgenes) therapeutics designed for precise, durable, one-time treatments.
The company focuses on creating PRINTed medicines to enable precise transgene insertion into genomic safe-harbor sites for chronic and rare disease indications and is advancing a pipeline of LNP-delivered RNA programs originating from UC Berkeley research.
Leadership & Board
Current Number of Employees66
Current LinkedIn Followers5,695
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Addition Therapeutics had 66 employees as of October 12, 2026. The number of employees decreased by 3 (4.35%) week-over-week.
66Latest Employee Count
3(-4.35%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Addition Therapeutics had 5,695 followers as of October 12, 2026. The number of followers increased by 22 (0.39%) week-over-week.
5,695Latest Followers Count
22(0.39%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.